标题: |
中国肾脏移植受者高尿酸血症临床诊疗指南(2023版) |
title: |
Chinese guideline for the clinical diagnosis and treatment of hyperuricemia in kidney transplant recipients (2023 edition) |
版本: |
原创版 |
version: |
Original |
分类: |
标准指南 |
classification: |
Standard guideline |
领域: |
诊疗 |
field: |
Diagnosis and Treatment |
国家和地区: |
中国 |
Country and
region:
|
China |
指南使用者: |
从事肾移植临床工作的医务人员 |
Guide users:
|
Medical staff engaged in clinical work of kidney transplantation |
证据分级方法: |
本指南采用2009年牛津大学证据等级分级体系对推荐意见的支持证据体进行评级推荐强度
证据等级 具体描述
A 1a 随机对照研究的系统评价
1b 结果可信区间小的随机对照研究
1c 显示“全或无效应”的任何证据
B 2a 队列研究的系统评价
2b 单个队列研究
2c 基于患者结局的研究
3a 病例对照研究的系统评价
3b 单个病例对照研究
C 4 病例系列报告、低质量队列研究和低质量病例对照研究
D 5 专家意见 |
Evidence grading
method:
|
This guide uses the 2009 Oxford University Evidence Grading System to rate the strength of the supporting evidence for recommendations
The level of evidence is specifically described
A 1a Systematic review of randomized controlled studies
1b Randomized controlled studies with small confidence intervals
1c shows any evidence of "all or no effect"
A systematic review of B2a cohort studies
2b Single cohort study
2c Study based on patient outcomes
3a Systematic review of case-control studies
3b Single case control study
4 Case series reports, low-quality cohort studies, and low-quality case-control studies
D 5 Expert opinion |
制定单位: |
中华医学会器官移植学分会 |
Formulating unit: |
Branch of Organ Transplantation, Chinese Medical Association |
注册时间: |
2024-01-11 |
Registration time: |
注册编号: |
PREPARE-2024CN157 |
Registration number: |
指南制订的目的: |
规范肾移植术后高尿酸血症的临床诊治 |
Purpose of the guideline:
|
To standardize the clinical diagnosis and treatment of hyperuricemia after renal transplantation |